RBC Capital Remains a Buy on Brookdale Senior Living (BKD)
In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on Brookdale Senior Living, with a price target of $17.00. The company’s shares closed yesterday at $13.11.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hendrix covers the Healthcare sector, focusing on stocks such as Brookdale Senior Living, CVS Health, and Acadia Healthcare. According to TipRanks, Hendrix has an average return of 5.1% and a 55.04% success rate on recommended stocks.
In addition to RBC Capital, Brookdale Senior Living also received a Buy from Bank of America Securities’s Joanna Gajuk in a report issued today. However, on the same day, TipRanks – OpenAI upgraded Brookdale Senior Living (NYSE: BKD) to a Hold.
Based on Brookdale Senior Living’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $777.84 million and a GAAP net loss of $114.73 million. In comparison, last year the company earned a revenue of $746.41 million and had a GAAP net loss of $50.72 million
Read More on BKD:
Disclaimer & DisclosureReport an Issue
- Brookdale Senior Living Issues Upbeat 2025 Preliminary Outlook
- Brookdale Senior Living sees 2025 revenue $3.2B, consensus $3.19B
- Brookdale Senior Living sees 2026 adjusted EBITDA $502M-$516M
- Brookdale Senior Living price target raised to $15 from $14 at Barclays
- Brookdale Senior Living Reports Strong Occupancy Momentum Into 2026
